In an ICC dispute, CRA was retained by respondent regarding the renegotiation of price in a supply agreement for a pharmaceutical sold in Japan. In expert reports and testimony, CRA evaluated the adequacy of returns made by respondent with request to development and commercialization of the product for the Japanese market.
2023 International Arbitration review: Updates and trends
2023 marked a significant surge in activity across diverse sectors such as mining, oil & gas, the energy transition, pharma, and merger disputes. Throughout...